ProtAffin AG granted patent in EU for CellJammer(R) discovery technology

proteins for the treatment of respiratory diseases such as COPD, and other autoimmune/inflammatory diseases (AAIDs). The approach combines bioinformatics, structure-based protein engineering and proprietary assays to develop novel, differentiated...